163
Participants
Start Date
June 30, 2015
Primary Completion Date
November 1, 2017
Study Completion Date
December 1, 2017
CERC-501
Oral dosing of 10 mg CERC-501 daily for 8 weeks
placebo
oral dosing of 10 mg placebo daily for 8 weeks
Icahn School of Medicine at Mount Sinai, New York
Duke University Medical Center, Durham
CaseWestern Reserve University, Cleveland
Baylor College of Medicine, Houston
Yale University, New Haven
Andrew Goddard, MD, Indianapolis
Lead Sponsor
Yale University
OTHER
Baylor College of Medicine
OTHER
Indiana University
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Case Western Reserve University
OTHER
Duke University
OTHER